References
Van Griethuysen A, Van’t Veen A, Buiting A, Walsh T, Klutymans J (2003) High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. J Clin Microbiol 41:2487–2491
Herrero IA, Issa NC, Patel R (2002) Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 346:867–869
Rybak MJ (2005) The efficacy and safety of daptomycin: first in a new class of antibiotics for gram-positive bacteria. Clin Microbiol Infect 12(Suppl 1):24–32
Samra Z, Ofer O, Shmuely H (2005) Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. IMAJ 7:148–150
Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing. 15th informational supplement. Approved standard MS100-S16. CLSI, Wayne, PA
Skov R, Fridmodt-Möller N, Espersen F (2001) Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis 40:111–116
Streit JM, Jones RN, Sader HS (2004) Daptomycin activity and spectrum: a worldwide sample of 6737 clinical gram-positive organisms. J Antimicrob Chemother 53:669–674
Denis O, Dplano A, Nonhoff C, Hallin M, De Ryck R, Vanhoof R, De Mendoca R, Struelens MJ (2006) In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agent Chemother 50:2680–2685
Jevitt LA, Smith AJ, Williams PP, Raney PM, McGowan JE Jr, Tenover FC (2003) In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Microb Drug Resist 9:389–393
Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE Jr, Tenover FC, Brown SD (2006) Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates. J Clin Microbiol 44:3098–3104
Acknowledgements
The authors thank Mrs. M. Kwe and G. Ginzach of the Editorial Board, Rabin Medical Center, and Beilinson Campus for their assistance. This work was not supported by any external funding and the authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Samra, Z., Ofir, O. & Shmuely, H. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium to daptomycin and other antibiotics. Eur J Clin Microbiol Infect Dis 26, 363–365 (2007). https://doi.org/10.1007/s10096-007-0288-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-007-0288-2